Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
04 2021
Historique:
received: 04 11 2020
revised: 31 12 2020
accepted: 06 02 2021
pubmed: 20 2 2021
medline: 23 9 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

To compare the atherosclerosis disease burden between ankylosing spondylitis (AS) and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a model that allows to identify high-cardiovascular (CV) risk in axial spondyloarthritis patients. Cross-sectional study from the AtheSpAin cohort, a Spanish multicenter cohort aimed to study atherosclerosis in axSpA. Carotid ultrasound (US) was performed to determine the carotid intima-media wall thickness (cIMT) and detect the presence of carotid plaques. The European cardiovascular disease risk assessment model, the Systematic COronary Risk Evaluation (SCORE), was also applied. A set of 639 patients with AS and 167 patients with nr-axSpA without history of CV events were recruited. AS patients were older showing more CV risk factors and higher values of C reactive protein and erythrocyte sedimentation rate (ESR) than those with nr-axSpA. However, no difference in the prevalence of carotid plaques or in the cIMT was found between both groups in the adjusted analysis. The percentage of patients reclassified from the low and moderate CV risk categories to the very high-risk category due to the presence of carotid plaques was comparable in AS and nr-axSpA (10.7% versus 10.1% and 40.5% versus 45.5%, respectively). A model containing age, BASFI and ESR applied to moderate risk axSpA patients identified 41% of these patients as having very high-risk patients with high specificity (88%). The atherosclerosis burden is similar in nr-axSpA and AS. As occurred for AS, more than 40% of axSpA patients included in the category of moderate CV risk according to the SCORE are reclassified into very high risk after carotid US, and a clinically relevant proportion of them can be detected by applying a model containing age, BASFI and ESR.

Identifiants

pubmed: 33607385
pii: S0049-0172(21)00020-2
doi: 10.1016/j.semarthrit.2021.02.003
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-403

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest I am pleased to inform that the authors of this manuscript have no competing interests to declare

Auteurs

Iñigo González Mazón (I)

Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Javier Rueda-Gotor (J)

Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Av. de Valdecilla, 25, 39008 Santander, Cantabria, Spain. Electronic address: ruedagotor@gmail.com.

Iván Ferraz-Amaro (I)

Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.

Fernanda Genre (F)

Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.

Alfonso Corrales (A)

Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Av. de Valdecilla, 25, 39008 Santander, Cantabria, Spain.

Vanesa Calvo Rio (V)

Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Natalia Palmou Fontana (N)

Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Virginia Portilla (V)

Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Javier Llorca (J)

Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain. Electronic address: llorcaj@unican.es.

Cristina Mata (C)

Rheumatology Division, Hospital Comarcal, Laredo, Cantabria, Spain.

Vanesa Hernández-Hernández (V)

Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. Electronic address: mvhhernandez@yahoo.es.

Juan Carlos Quevedo-Abeledo (JC)

Rheumatology Division, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. Electronic address: quevedojcarlos@yahoo.es.

Carlos Rodríguez-Lozano (C)

Rheumatology Division, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. Electronic address: crlormar@gmail.com.

Clementina Lopez Medina (C)

Rheumatology Division, Hospital Universitario Reina Sofía, Córdoba, Spain. Electronic address: clementinalopezmedina@gmail.com.

María Lourdes Ladehesa-Pineda (ML)

Rheumatology Division, Hospital Universitario Reina Sofía, Córdoba, Spain. Electronic address: lourdesladehesapineda@gmail.com.

Santos Castañeda (S)

Rheumatology Division, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain. Electronic address: scastas@gmail.com.

Esther F Vicente (EF)

Rheumatology Division, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain. Electronic address: efvicenter@gmail.com.

Cristina Fernández-Carballido (C)

Rheumatology Division, Hospital Universitario de San Juan, Alicante, Spain. Electronic address: soficarballido@hotmail.com.

María Paz Martínez-Vidal (MP)

Rheumatology Division, Hospital General Universitario de Alicante, Alicante, Spain. Electronic address: mpmavidal@yahoo.es.

David Castro-Corredor (D)

Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain. Electronic address: d.castrocorredor@gmail.com.

Joaquín Anino-Fernández (J)

Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain. Electronic address: michaelturra@hotmail.com.

Diana Peiteado (D)

Rheumatology Division, Hospital La paz, Madrid, Spain. Electronic address: diana.peiteado@salud.madrid.org.

Chamaida Plasencia-Rodríguez (C)

Rheumatology Division, Hospital La paz, Madrid, Spain. Electronic address: chamiplaro@gmail.com.

María Luz García-Vivar (ML)

Rheumatology Division, Hospital Universitario Basurto, Bilbao, Spain. Electronic address: marialuz.garciavivar@osakidetza.eus.

Eva Galíndez-Agirregoikoa (E)

Rheumatology Division, Hospital Universitario Basurto, Bilbao, Spain. Electronic address: eva.galindezaguirregoikoa@osakidetza.eus.

Esther Montes Perez (E)

Diagnóstico Médico Cantabria (DMC), Santander, Spain. Electronic address: esmonpe13@hotmail.com.

Carlos Fernández Díaz (C)

Rheumatology división, Hospital 12 de Octubre, Madrid, Spain. Electronic address: carlos.fdez.diaz1@gmail.com.

Ricardo Blanco (R)

Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Av. de Valdecilla, 25, 39008 Santander, Cantabria, Spain. Electronic address: ricardo.blanco@scsalud.es.

Miguel Angel González-Gay (MA)

Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Av. de Valdecilla, 25, 39008 Santander, Cantabria, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, South Africa. Electronic address: miguelaggay@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH